Androgen-Estrogen Metabolism in Women with Upper BodyVersusLower Body Obesity*

Abstract

Androgen and estrogen production rates were examined in 29 morbidly obese women with upper of lower body obesity. Although blood production rates of testosterone (T), dihydrotestosterone, and androstenedione (A4) were elevated in all of these women, those with upper body obesity (waist-height ratios, >0.85) had higher T and production rates than women with lower body obesity (waist-height ratio <0.75). A4 was equally elevated in women with upper and lower body obesity. Peripheral aromatization of A4 to estrone (E1) averaged 1.67% in women with upper body obesity, but was elevated at 2.54% in women with lower body obesity. Urinary E1 production rates averaged 466.+-.295 nmol/day (172.+-.109 .mu.g/day) in women with lower body obesity compared to 356 .+-. 241 (132 .+-. 89) in women with upper body obesity. Thus, women with lower body obesity had higher E1 production rates due entirely to increased peripheral aromatization. Women with upper body obesity were observed to have higher serum T and estradiol (E2) levels than women with lower body obesity. Further, upper body obesity was associated with decreased levels of sex hormone-binding globulin (16.1 .+-. 5.7 nmol/L vs. 18.9 .+-. 6.1 in women with lower body obesity). As a result, free T levels averaged 98.8 .+-. 39.2 pmol/L in women with upper body obesity vs. 82.2 .+-. 33 in women with lower body obesity. Similarly, serum free E2 levels were higher in women with upper body vs. lower body obesity. The data demonstrate that sex hormone production and metabolism are different in morbidly obese women with these differing phenotypes. Women with upper body obesity have higher androgen production rates and higher free T and free E2 levels, whereas women with lower body obesity make increased amounts of E1 from peripheral aromatization. The biological significance of increased aromatization may be offset by increased free E2 levels in women with upper body obesity.